M. Carmel

发表

Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3

Robert W. Mills, A J Agopian, Jonathan H. Chung, 2017, Circulation. Cardiovascular genetics.

Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the &ITGPR98&IT Locus on 5q14.3

A J Agopian, Jonathan H. Chung, E. Zackai, 2022 .

Differential methylation of imprinting genes and MHC locus in 22q11.2 deletion syndrome-related schizophrenia spectrum disorders

Abraham Weizman, A. Frisch, D. Gothelf, 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Genotype-phenotype correlation in 22q11.2 deletion syndrome

Abraham Weizman, L. Basel‐Vanagaite, T. Green, 2012, BMC Medical Genetics.

Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.

Abraham Weizman, T. Green, A. Frisch, 2014, Journal of psychiatric research.

Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study

V. Roessner, R. Bond, D. Martino, 2021, European Child & Adolescent Psychiatry.

Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

Abraham Weizman, N. Melhem, D. Brent, 2009, Journal of Neural Transmission.

The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.

Abraham Weizman, Alon Chen, A. Apter, 2016, Journal of child and adolescent psychopharmacology.

Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders

Abraham Weizman, Alon Chen, D. Brent, 2016, Journal of Neural Transmission.

The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.

E. Friedman, A. Figer, M. Carmel, 2001, Genetic testing.

Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach

Abraham Weizman, M. Salmon-Divon, A. Frisch, 2019, Translational Psychiatry.

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

Alex V. Kotlar, Sunny X. Tang, E. Zackai, 2020, Molecular Psychiatry.

Runs of homozygosity, copy number variation, and risk for depression and suicidal behavior in an Arab Bedouin kindred

L. Klei, Shawn Wood, B. Devlin, 2017, Psychiatric genetics.

Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.

Abraham Weizman, G. Zalsman, D. Brent, 2013, Journal of child and adolescent psychopharmacology.

A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes

Abraham Weizman, A. Diamond, D. Abbott, 2014, European Psychiatry.

Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome

Abraham Weizman, A. Simon, R. Somech, 2015, Pediatric Research.

Thymic and bone marrow output in individuals with 22 q 11 . 2 deletion syndrome Short title : Immunodeficiency in 22 q 11 . 2 deletion

Abraham Weizman, A. Simon, R. Somech, 2015 .

Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome

B. Kolachana, D. Weinberger, Abraham Weizman, 2014, Biological Psychiatry.

Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.

Abraham Weizman, A. Apter, M. Korostishevsky, 2008, The international journal of neuropsychopharmacology.

Thalidomide-induced heart block in a dialysis patient Sir, We report the case of a patient with thalidomide-induced third-degree heart block when used in context of myeloma and acute renal failure. An 88-year-old female patient was commenced

M. Carmel, Johnson, Alicia Smith, 2009 .

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.

Abraham Weizman, N. Melhem, D. Brent, 2007, Journal of child and adolescent psychopharmacology.

Hyperactive auditory processing in Williams syndrome: Evidence from auditory evoked potentials.

Abraham Weizman, T. Green, A. Frisch, 2015, Psychophysiology.

Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome

D. Gothelf, M. Taler, M. Carmel, 2019, American journal of medical genetics. Part A.

Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome

E. Zackai, R. Gur, R. Gur, 2016, European Neuropsychopharmacology.

Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.

Abraham Weizman, T. Green, A. Frisch, 2013, Journal of psychiatric research.

Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.

Abraham Weizman, A. Apter, A. Frisch, 2008, Pharmacogenomics.

Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the &ITGPR98&IT Locus on 5q14.3

A J Agopian, Jonathan H. Chung, E. Zackai, 2022 .

Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

S. Scherer, M. Owen, R. Gur, 2020, Nature Medicine.

The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.

Abraham Weizman, Alon Chen, A. Apter, 2016, Journal of child and adolescent psychopharmacology.

Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder

D. Gothelf, M. Carmel, E. Michaelovsky, 2024, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.